J&J Petitions Supreme Court On Pre-emption, ‘Clear Evidence’ In OTC Litigation
This article was originally published in The Tan Sheet
Executive Summary
Johnson & Johnson files a writ of certiorari asking the Supreme Court to review a $140m judgment against the firm in Massachusetts. Questions over “clear evidence” needed for FDA decision to pre-empt state courts are at heart of issue and need the court’s consideration.
You may also be interested in...
FTC Review Of Colgate Optic White Claims Stalls Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, says a federal judge in response to Colgate’s motion to dismiss or stay the litigation. The judge denied the firm’s motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.
FTC Review Of Colgate Optic White Claims Delays Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, a federal judge rules. The judge denied the Colgate's motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.
FTC Review Of Colgate Optic White Claims Delays Class Action Complaint
A Colgate Optic White whitening claims class action complaint is stayed pending an FTC decision on the claims, a federal judge rules. The judge denied the Colgate's motion to dismiss on the grounds the state suit is pre-empted by FDA regulations.